Table 1 Characteristics of breast cancer patients
Patient’s characteristics | Total No. = 8 No. (%) |
|---|---|
Age (years) | |
 Mean ± SD | 40 ± 7.01 |
 Median | 41 |
 Range | 29-48 |
Stage at diagnosis | |
 II | 2/8 (25%) |
 III | 5/8 (62.5%) |
 IV | 1/8 (12.5%) |
Immunohistochemistry ER status | |
 Positive | 5/8 (62.5%) |
 Negative | 3/8 (37.5%) |
PR status | |
 Positive | 4/8 (50%) |
 Negative | 4/8 (50%) |
HER2 neu | |
 Positive | 1/8 (12.5%) |
 Negative | 7/8 (87.5%) |
KI 67 | |
 High | 4/8 (50%) |
 Low | 1/8 (12.5%) |
 Unknown | 3/8 (37.5%) |
Molecular subtype | |
 Luminal A | 1/8 (12.5%) |
 Luminal B | 4/8 (50%) |
 Triple negative disease | 3/8 (37.5%) |
Metastasis | |
 Metastatic: | 6/8 (75%) |
 Liver | 4/6 (66.7%) |
 Bone | 3/6 (50%) |
 Lung | 4/6 (66.7%) |
 Brain | 0 |
 Local recurrence | 1/6 (16.7%) |
 Early disease, non metastatic: | 2/8 (25%) |
Microsatellite instability (MSI) status | |
 Microsatellite stable (MSS) | 2/8 (25%) |
 Microsatellite instability-low (MSI-L) | 3/8 (37.5%) |
 Microsatellite instability-high (MSI-HI) | 3/8 (37.5%) |